A multicenter, randomized, double-blind, placebo-controlled TRial evaluating Immunosuppressive treatment in patients with chronic virus-Negative Inflammatory cardiomyopaThY (TRINITY trial)
This research study, called TRINITY, is looking for new ways to treat a heart condition known as inflammatory cardiomyopathy. This is when the heart muscle becomes inflamed, and for people in this study, it's not caused by a virus. Participants in the study have hearts that aren't pumping as well as they should, even with their usual heart medications. The study will test if a combination of medicines (prednisolone and Mowel, also known as mycophenolate mofetil) can help the heart pump more strongly. Half the participants will get these study medicines, and the other half will get dummy pills (placebo). This helps doctors see if the study drugs are truly making a difference. The main goal is to see if these medicines improve how well the heart pumps blood and if they can prevent serious heart-related problems over 12 months.
At a glance
What is this study about?
You might be reading this because you, or someone you know, has a heart condition called inflammatory cardiomyopathy. This is when the heart muscle becomes inflamed, making it harder for your heart to pump blood effectively. For the people taking part in this study, their heart problems aren't caused by a virus and haven't improved enough with their usual treatments. This can be a very challenging problem, and doctors are always looking for better solutions.
This study, called TRINITY, is a very important step. It's designed to see if certain medicines, which help to calm down the body's immune system (the system that fights off infections), can help your heart get stronger. The medicines being tested are called prednisolone and Mowel (which is also known as mycophenolate mofetil). These medicines are already used for other conditions, but this study specifically looks at how well they work for this particular heart problem. By knowing this, doctors hope to offer more effective treatments in the future.
Since this is an 'integrated Phase II and Phase III' study, it means it's testing both the safety and effectiveness of the treatments in one large program. It involves a lot of careful measurements over a year to understand if these medicines can truly make a difference in how well your heart pumps blood, improve your quality of life, and potentially prevent serious heart events. Half the participants will receive the active study medicines, and the other half will receive harmless dummy pills (placebo). This is a standard and necessary step in medical research to ensure any observed benefits are truly due to the study drugs and not just other factors.
Key takeaways
- This study aims to find better treatments for inflamed heart muscles not caused by viruses.
- It tests specific immune-calming medicines: prednisolone and Mowel.
- Participants will receive either the study medicines or a dummy pill.
- The study lasts 12 months with regular heart health checks.
- Results will help doctors understand if these drugs improve heart pumping and overall health.
Who may be eligible?
This study is looking for adults aged 18 or older.
To be considered for this study, you must have a specific heart condition called "virus-negative inflammatory cardiomyopathy." This means your heart muscle is inflamed, but doctors have confirmed it's not due to a virus. Your heart's pumping ability would also be weaker than it should be, and this hasn't improved enough even while you're taking the best available standard heart medications for heart failure.
There will be other detailed medical checks to make sure the study is a safe and suitable option for you. Your heart specialist will be able to tell you if you meet all the necessary requirements.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been diagnosed with inflammatory cardiomyopathy that isn't caused by a virus?
- Is your heart's pumping ability weaker than it should be?
- Are you currently on the best available standard medications for heart failure, but your heart hasn't improved enough?
What does participation involve?
If you join this study, it will last for 12 months. Since this is a 'double-blind' study, neither you nor your doctor will know whether you are receiving the active study medicines (prednisolone and Mowel) or a dummy pill (placebo). All study medicines, whether active or placebo, will look identical.
Your participation will involve regular visits to the hospital or clinic over this 12-month period. During these visits, doctors will closely monitor your heart function using detailed scans like MRI (Magnetic Resonance Imaging) and ultrasound (echo). They will also check your overall heart health, your ability to exercise, how you feel day-to-day (quality of life), and any changes in your symptoms. There will be other assessments like blood tests to monitor your health and how your body is responding to the treatment.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is inflammatory cardiomyopathy?
It's a condition where your heart muscle becomes inflamed, making it harder for your heart to pump blood effectively around your body.
What does 'virus-negative' mean?
It means doctors have checked, and your heart inflammation is not caused by a viral infection.
Why will some people get a dummy pill?
Giving some people a dummy pill (placebo) helps researchers fairly compare if the study medicines are truly making a difference compared to no active treatment.
What are prednisolone and Mowel?
These are medicines that help control your body's immune system, which might help reduce the inflammation in your heart.
How long will the study last if I join?
If you participate, the treatment and monitoring part of the study will last for 12 months.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.